EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Association Between Hepatic Steatosis and Deterioration of Metabolic Health in Obese Individuals: A 12‐Year Follow‐Up of the Tehran Lipid and Glucose Study

Behnaz Abiri, Mohammad Nikoohemmat, Maryam Mahdavi, Amirhossein Ramezani Ahmadi, Majid Valizadeh, Fereidoun Azizi, Farhad Hosseinpanah

Endocrinology, Diabetes & Metabolism · 2026

DOI: 10.1002/edm2.70156 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrinology, Diabetes & Metabolism, 2026. Verfasst von Behnaz Abiri und 6 weiteren Autor:innen. Beteiligte Einrichtung: Obesity Research Center, Research Institute for Metabolic and Obesity Disorders, Research Institute for Endocrine Sciences, Shahid Beheshti Universit…. Hauptthemen laut MEDLINE: Obesity, Fatty Liver, Obesity, Metabolically Benign. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Uncertainty surrounds the relationship between metabolic decline and fatty liver disease. The purpose of this study was to evaluate the effect of hepatic steatosis (HS) on the transition from metabolically healthy obesity (MHO) to metabolically unhealthy obesity (MUO) and to determine whether the Fatty Liver Index (FLI) can predict this progression.

Methods

In this prospective cohort research, participants in the Tehran Lipid and Glucose Study (TLGS) comprised 593 MHO adults who were at least 40 years old at baseline. The subjects were followed up for a period of 12 years to see if the subjects' metabolically healthy obesity phenotype changed to an unhealthy one. The body mass index (BMI) of 30.0 kg/m 2 was used to characterise obesity. The concept of metabolically healthy (less than two variables) or metabolically abnormal (two or more) was based on four metabolic parameters: low high density lipoprotein‐cholesterol (HDL‐c) concentration, hypertension, hypertriglyceridemia, and impaired fasting glucose. The technique used to construct the fatty liver index (FLI), which serves as an indication of HS, was based on waist circumference (WC), triglycerides, BMI, and gamma‐glutamyl transferase.

Results

During a median of 4.81 years of follow‐up (interquartile range 1.75–10.74 years), 72.2% ( n = 428) of MHO individuals transitioned to the MUO phenotype. Transitioning participants exhibited higher FLI scores, BMI, waist circumference, and unfavourable metabolic profiles compared to non‐transitioning participants. Cox regression analysis revealed that hepatic steatosis (HR: 1.369; 95% CI: 1.014–1.848), lower physical activity (HR: 1.267; 95% CI: 1.035–1.551), and a higher TyG index (HR: 3.208; 95% CI: 1.546–6.657) were significant predictors of transition to MUO.

Conclusion

Hepatic steatosis at baseline is an independent risk factor for progression from metabolically healthy status to metabolically abnormal phenotype in obese individuals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ObesityFatty LiverObesity, Metabolically BenignHumansMaleFemaleFollow-Up StudiesIranMiddle AgedAdultProspective StudiesBody Mass IndexDisease ProgressionBlood GlucoseWaist CircumferenceRisk Factors

Stichwörter der Autor:innen

fatty liver indexhepatic steatosismetabolically healthy obesitymetabolically unhealthy obesitytransition of obesity phenotype

Substanzen

Blood Glucose

Autor:innen und Institutionen

  • Obesity Research Center, Research Institute for Metabolic and Obesity Disorders, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Isfahan Endocrine and Metabolism Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Science, Tehran, Iran.

Zitieren

APA

Abiri, B., Nikoohemmat, M., Mahdavi, M., Ahmadi, A. R., Valizadeh, M., Azizi, F., & Hosseinpanah, F. (2026). Association Between Hepatic Steatosis and Deterioration of Metabolic Health in Obese Individuals: A 12‐Year Follow‐Up of the Tehran Lipid and Glucose Study. Endocrinology, Diabetes & Metabolism. https://doi.org/10.1002/edm2.70156

Vancouver

Abiri B, Nikoohemmat M, Mahdavi M, Ahmadi AR, Valizadeh M, Azizi F, et al. Association Between Hepatic Steatosis and Deterioration of Metabolic Health in Obese Individuals: A 12‐Year Follow‐Up of the Tehran Lipid and Glucose Study. Endocrinology, Diabetes & Metabolism. 2026. doi:10.1002/edm2.70156

BibTeX
@article{Abiri2026,
  author = {Abiri, Behnaz and Nikoohemmat, Mohammad and Mahdavi, Maryam and Ahmadi, Amirhossein Ramezani and Valizadeh, Majid and Azizi, Fereidoun and Hosseinpanah, Farhad},
  title = {Association Between Hepatic Steatosis and Deterioration of Metabolic Health in Obese Individuals: A 12‐Year Follow‐Up of the Tehran Lipid and Glucose Study},
  journal = {Endocrinology, Diabetes & Metabolism},
  year = {2026},
  doi = {10.1002/edm2.70156}
}
Kostenlos starten →